David P. Meeker - Feb 9, 2022 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
President and CEO, Director
Signature
/s/ Hunter C. Smith, attorney-in-fact for David P. Meeker
Stock symbol
RYTM
Transactions as of
Feb 9, 2022
Transactions value $
$0
Form type
4
Date filed
2/11/2022, 08:33 PM
Previous filing
Jun 17, 2021
Next filing
Jul 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Award $0 +510K $0.00 510K Feb 9, 2022 Common Stock 510K $6.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted on February 9, 2022. The option vests and becomes exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.